Japer Therapeutics Warrants
JSPRW
35 hedge funds and large institutions have $4.99M invested in Japer Therapeutics Warrants in 2020 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 12 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
10% more capital invested
Capital invested by funds: $4.51M → $4.99M (+$473K)
0% more funds holding
Funds holding: 35 → 35 (0)
83% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OAC
OMERS Administration Corp
Toronto,
Ontario, Canada
|
+$53.3K |
| 2 |
GCL
Glazer Capital LLC
New York
|
+$46.6K |
| 3 |
ES
Equitec Specialists
Chicago,
Illinois
|
+$36.6K |
| 4 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
+$5.27K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SRCM
Sage Rock Capital Management
New York
|
-$404K |
| 2 |
AIMCA
Alberta Investment Management Corp (AIMCo)
Edmonton,
Alberta, Canada
|
-$53.9K |
| 3 |
BCM
Basso Capital Management
Stamford,
Connecticut
|
-$51.3K |
| 4 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$48K |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
-$47.8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CCM
26
Context Capital Management
Lajolla,
California
| $36K | – | – | – |
|
27
Walleye Trading
New York
| $30K | -$11.5K | -9,210 | -31% |
|
|
BCM
28
Basso Capital Management
Stamford,
Connecticut
| $26K | -$51.3K | -40,900 | -69% |
|
|
CAC
29
Cowen and Company
New York
| $22K | – | – | – |
|
30
Geode Capital Management
Boston,
Massachusetts
| $20K | -$3.07K | -2,445 | -15% |
|
|
EIP
31
Easterly Investment Partners
Beverly,
Massachusetts
| $15K | – | – | – |
|
|
PAM
32
Panagora Asset Management
Boston,
Massachusetts
| $5K | -$181 | -144 | -4% |
|
33
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
34
Walleye Capital
New York
| $48 | -$22.3K | -17,790 | -35% |
|
|
PC
35
Periscope Capital
Toronto,
Ontario, Canada
| – | -$48K | -41,368 | Closed |
|
|
DIG
36
DeepCurrents Investment Group
New York
| – | -$36.5K | -29,136 | Closed |
|
37
UBS Group
Zurich,
Switzerland
| – | -$356 | -284 | -96% |
|
JSPRW Hedge Fund Activity: Q4 2020 in Review
35 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Japer Therapeutics Warrants (JSPRW) for Q4 2020, worth a combined $4.99M — up 10% from $4.51M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new JSPRW positions and 2 closed out — a net gain of 1 holder — while 2 added to existing stakes and 12 trimmed.
The largest buyer was OMERS Administration Corp, opening a new position worth an estimated $53.3K. The largest seller was Sage Rock Capital Management, cutting an estimated $404K.
- 35 institutional investors held Japer Therapeutics Warrants (JSPRW) as of Q4 2020, unchanged from Q3 2020.
- Funds reported $4.99M of Japer Therapeutics Warrants stock for Q4 2020, up 10% quarter-over-quarter.
- 3 funds opened new Japer Therapeutics Warrants positions in Q4 2020 and 2 closed out, a net change of +1 holder.
- The largest Japer Therapeutics Warrants buyer in Q4 2020 was OMERS Administration Corp, an estimated $53.3K added.
- The largest Japer Therapeutics Warrants seller in Q4 2020 was Sage Rock Capital Management, an estimated $404K sold.
Based on aggregated 13F filings for Q4 2020.